跳至主要内容
临床试验/DRKS00010082
DRKS00010082已完成不适用

EUDOR-A Multi-centre Research ProgramA Naturalistic, European Multi-centre Clinical Study of EDOR Test in adult patients with primary depression - EUDOR-A

Emotra AB0 个研究点目标入组 1,569 人开始时间: 2016年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,569

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • In- and outpatients with a primary diagnosis of depression according to the ICD-10, also in remission;
  • -Age: 18 years or older;
  • -Gender: Any;
  • -Signed Informed Consent.

排除标准

  • -Patient’s dissent to participate in the study;
  • -In cases of diagnosed or suspected dementia, the patient should to be excluded unless there is a special interest by the centre. If included, this condition must be noted;
  • -In cases of known or suspected alcohol or other substance abuse, the patient has to be excluded unless there is a special interest by the centre. If included, this condition must be noted;
  • -Patient’s inability to understand the instructions for the EDOR Test;
  • -Serious problems of hearing.

研究者

发起方
Emotra AB

相似试验

进行中(未招募)
不适用
An Exploratory Multi-Centre, Multi-National, Randomised, Double Blinded, Parallel Arm Trial Evaluating Safety, Pharmacokinetics and Dose-finding of prophylactic administration of Long Acting rFVIIa (LA-rFVIIa) in Haemophilia A or B Patients with InhibitorsHaemophilia A (Factor VIII) or B with InhibitorsMedDRA version: 9.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)MedDRA version: 9.1Level: LLTClassification code 10060612Term: Hemophilia A
EUCTR2008-006424-54-SEovo Nordisk A/S24
进行中(未招募)
不适用
An Exploratory Multi-Centre, Multi-National, Randomised, Double Blinded, Parallel Arm Trial Evaluating Safety, Pharmacokinetics and Dose-finding of prophylactic administration of Long Acting rFVIIa (LA-rFVIIa) in Haemophilia A or B Patients with InhibitorsHaemophilia A (Factor VIII) or B with InhibitorsMedDRA version: 9.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)MedDRA version: 9.1Level: LLTClassification code 10060612Term: Hemophilia A
EUCTR2008-006424-54-GBovo Nordisk A/S24
进行中(未招募)
1 期
An Exploratory Multi-Centre, Multi-National, Randomised, Double Blinded, Parallel Arm Trial Evaluating Safety, Pharmacokinetics and Dose-finding of prophylactic administration of Long Acting rFVIIa (LA-rFVIIa) in Haemophilia A or B Patients with Inhibitors
EUCTR2008-006424-54-FRovo Nordisk A/S
进行中(未招募)
不适用
A multi-centre, multi-national open study in patients with hepatic cirrhosis to characterise the association between the pharmacokinetics of NRL972 and disease severity - NRL972 in hepatic cirrhosisHepatic cirrhosis.MedDRA version: 9.1Level: PTClassification code 10019641Term: Hepatic cirrhosis
EUCTR2007-002404-18-ATorgine Limited1,200
进行中(未招募)
不适用
A multi-centre, multi-national open study in patients with hepatic cirrhosis to characterise the association between the pharmacokinetics of NRL972 and disease severity - NRL972 in hepatic cirrhosis
EUCTR2007-002404-18-BEorgine Limited1,200